New Jersey Gov. Chris Christie's secret gastric band surgery in February has stolen front-page headlines today. His weight is often the target of comedic fodder, but it was a legitimate concern surrounding his overall health.
This news has gotten the political media stirring that the governor is planning a White House run in 2016, but here at the Fool we're more concerned with investing than with politics. With more than 200,000 stomach-shrinking procedures performed per year, is there money to be made for investors?
In this video, Motley Fool health-care analyst David Williamson takes a closer look at the companies and highlights why this may be no slam-dunk for investors.
What could be a slam-dunk for investors is a stock working to eradicate the macro trend Warren Buffett called "the tapeworm that's eating at American competitiveness." Find out what Buffett was referring to in our free report: "What's Really Eating at America's Competitiveness." Just click here for free, immediate access.
Follow David on Twitter: @MotleyDavid.